Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma

BACKGROUND: Advanced melanoma patients have an extremely poor long term prognosis and are in strong need of new therapies. The recently developed targeted therapies have resulted in a marked antitumor effect, but most responses are partial and some degree of toxicity remain the major concerns. Dendr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Med
Main Authors: Rozera, Carmela, Cappellini, Giancarlo Antonini, D’Agostino, Giuseppina, Santodonato, Laura, Castiello, Luciano, Urbani, Francesca, Macchia, Iole, Aricò, Eleonora, Casorelli, Ida, Sestili, Paola, Montefiore, Enrica, Monque, Domenica, Carlei, Davide, Napolitano, Mariarosaria, Rizza, Paola, Moschella, Federica, Buccione, Carla, Belli, Roberto, Proietti, Enrico, Pavan, Antonio, Marchetti, Paolo, Belardelli, Filippo, Capone, Imerio
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4438625/
https://ncbi.nlm.nih.gov/pubmed/25933939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-015-0473-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados